LJ-2698
LJ-2698 (FM101) is an orally active adenosine A3 receptor (Adenosine A3 Receptor) antagonist. LJ-2698 blocks adenosine A3 receptor-dependent pro-inflammatory JNK, ERK, and NF-κB signaling pathways. LJ-2698 prevents alveolar cavity enlargement, restores pulmonary function, and inhibits matrix metalloproteinase activity and pulmonary cell apoptosis (apoptosis) in mice. LJ-2698 induces mitochondrial dysfunction, necroptosis, and intrinsic apoptosis. LJ-2698 ameliorates renal injury in mice with diabetic nephropathy, and alleviates diet-induced hepatic inflammation and fibrosis. LJ-2698 can be used in the research of emphysema, diabetic nephropathy, and metabolic dysfunction-associated steatotic liver disease.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 945457-84-1
- 화학식: C16H15Cl2N5O2S
- 분자량:412.29
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | Inhibition |
38 %
Compound: 9b
|
Displacement of [3H]CCPA from human adenosine A1 receptor in CHO cells at 10 uM
Displacement of [3H]CCPA from human adenosine A1 receptor in CHO cells at 10 uM
|
[PMID: 17555308] |
| HEK293 | Inhibition |
18 %
Compound: 9b
|
Displacement of [3H]CGS21680 from human adenosine A2A receptor expressed in HEK293 cells at 10 uM
Displacement of [3H]CGS21680 from human adenosine A2A receptor expressed in HEK293 cells at 10 uM
|
[PMID: 17555308] |
In Vitro
LJ-2698 (0.1 μM, 72 h) restores the expression of anti-inflammatory cytokines (Il4, Il10) and M2 macrophage markers (Arg1, Mrc1) in LPS (HY-D1056)-stimulated RAW 264.7 murine macrophages[1].
LJ-2698 (1 μM) potently and selectively inhibits A3AR with an inhibition rate of 88%[3].
LJ-2698 (2-4 μM; 6 h) induces β-arrestin2-mediated lysosomal degradation of A3AR in LPS-stimulated ImKC, and inhibits A3AR-dependent pro-inflammatory signaling pathways, including JNK, ERK and NF-κB[3].
LJ-2698 (2-4 μM; 6-24 h) exerts anti-inflammatory effects in LPS-stimulated primary mouse Kupffer cells and THP-1 human macrophage-like cells by downregulating the expression of pro-inflammatory cytokine genes and the secretion of TNF-α[3].
LJ-2698 (4 μM) induces mitochondrial dysfunction in primary mouse Kupffer cells, HeLa cells, and LPS-stimulated ImKC, including inhibited respiration, reduced ATP production, increased number of damaged mitochondria, and elevated mitochondrial superoxide levels, and its anti-inflammatory effect depends on mitochondrial integrity[3].
LJ-2698 (4 μM; 12 h) activates the p53/AKT1/GSK3β/β-catenin signaling cascade to trigger necroptosis as the dominant cell death pathway, induce mild endogenous apoptosis, and inhibit pyroptosis and exogenous apoptosis in LPS-stimulated ImKC[3].
LJ-2698 (4 μM; 24 h) selectively induces cytotoxicity in LPS-stimulated ImKC and PA-treated hepatocytes, but exerts no such effect in unstimulated ImKC, HSC, or BSA-treated hepatocytes[3].
LJ-2698 (4 μM; 12 h) selectively targets proinflammatory monocyte-derived Kupffer cells (MoKCs) by downregulating proinflammatory gene expression, upregulating cell death-related gene expression and inducing cytotoxicity, while exerting no effect on embryo-derived Kupffer cells (EmKCs)[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:RAW 264.7 (murine macrophage)
-
Concentration:0.1 μM
-
Incubation Time:48 h (pretreatment); 24 h (co-incubation with LPS)
-
Result:Significantly ameliorated LPS-mediated downregulation of Il4 and Il10 anti-inflammatory cytokine mRNA expression.
Significantly restored LPS-mediated downregulation of Arg1 and Mrc1 M2 macrophage marker mRNA expression.
-
Cell Line:immortalized mouse Kupffer cells (ImKCs)
-
Concentration:2 μM, 4 μM, 4 μM (with wortmannin)
-
Incubation Time:6 h (2 μM, 4 μM); treatment duration not specified (4 μM with wortmannin)
-
Result:Reduced A3AR and β-arrestin2 protein levels significantly in LPS-stimulated ImKCs.
Left β-arrestin1 levels unchanged.
Rescued A3AR and β-arrestin2 protein levels when co-treated with wortmannin.
Showed a strong positive correlation between A3AR and β-arrestin2 protein expression.
Reduced levels of phosphorylated JNK, ERK, and IκB-α significantly in LPS-stimulated ImKCs.
-
Cell Line:immortalized mouse Kupffer cells (ImKCs)
-
Concentration:4 μM
-
Incubation Time:12 h
-
Result:Activated the p53/AKT1/GSK3β/β-catenin signaling cascade in LPS-stimulated ImKCs.
Elevated levels of phosphorylated RIP3 and MLKL (key necroptosis markers) markedly.
Increased cleaved caspase-3 (intrinsic apoptosis marker).
Decreased cleaved caspase-8, caspase-7, caspase-1, and GSDMD (pyroptosis and extrinsic apoptosis markers).
In Vivo
Oral administration of LJ-2698 (1.5-10 mg/kg; p.o.; daily; 12 weeks) for 12 weeks improves diabetic nephropathy in db/db mice in a dose-dependent manner, and the 10 mg/kg dose exhibits the most stable and comprehensive renoprotective effects across all tested indicators[2].
FM101 (30-60 mg/kg; p.o.; daily; 6 weeks), administered daily at doses of 30 or 60 mg/kg for 6 weeks, improves FFD-induced MASLD in C57BL/6 N mice by alleviating hepatic inflammation, fibrosis, and the number of proinflammatory monocyte-derived Kupffer cells; the 60 mg/kg dose also reduces liver weight and liver-to-body weight ratio[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:FVB mice (8-week-old)[1]
-
Dosage:50 μg/kg
-
Administration:p.o.; 6 times per week; 5 weeks
-
Result:Restored lung compliance and tissue elasticity to levels closer to control mice.
Markedly suppressed PPE-induced airspace enlargement and reduced the elevated PPE-induced mean linear intercept (MLI).
Suppressed PPE-mediated increases in matrix metalloproteinase gelatinase activity in lung tissue.
Significantly reduced the number of TUNEL-positive apoptotic cells in the lungs compared to PPE-only treated mice.
Restored PPE-induced downregulation of anti-inflammatory cytokine (Il4, Il10) and M2 macrophage marker (Arg1, Mrc1/CD206) mRNA expression in lung tissue.
Increased the number of CD206-positive M2 macrophages per field in lung tissue.
Caused no significant changes in body weight compared to control or PPE-only groups, indicating minimal toxicity.
-
Animal Model:C57BLKS/J-db/db (male, 8 weeks old)[2]
-
Dosage:1.5 mg/kg; 5 mg/kg; 10 mg/kg
-
Administration:p.o.; daily; 12 weeks
-
Result:Significantly reduced elevated glomerular volume and fractional mesangial area across all three doses, with no significant differences between doses.
Significantly reduced increased urinary albumin excretion at 5 and 10 mg/kg doses; did not produce a significant reduction at 1.5 mg/kg dose.
Significantly prevented reduced nephrin mRNA levels and increased NGAL mRNA levels at 10 mg/kg dose.
Significantly inhibited increased TGF-β mRNA levels at 10 mg/kg dose; did not produce a significant reduction at 1.5 and 5 mg/kg doses.
Significantly reduced increased collagen IV and fibronectin mRNA levels at 5 and 10 mg/kg doses.
Significantly reduced elevated MCP-1 mRNA levels at 5 and 10 mg/kg doses; significantly inhibited increased ICAM-1 mRNA levels at 10 mg/kg dose, while 1.5 and 5 mg/kg doses did not.
Significantly decreased increased urinary LPO levels at 5 and 10 mg/kg doses.
-
Animal Model:C57BL/6N (age 8 weeks at study start; fed high-fat, high-cholesterol fast-food diet with fructose and glucose in drinking water for 24 weeks)[3]
-
Dosage:30 mg/kg; 60 mg/kg
-
Administration:p.o.; daily; 6 weeks
-
Result:Significantly reduced body weight, serum alanine aminotransferase (ALT) levels, serum cholesterol levels, NAFLD Activity Score, hepatic collagen deposition (Sirius Red-positive area), mRNA expression of pro-inflammatory genes (Ccl2, Ccl3, Cxcl2), mRNA expression of profibrogenic genes (Col1a1, Col1a4, Lox, Timp1), hepatic levels of phosphorylated AKT, JNK, and P65, and the percentage of CLEC4F-positive Kupffer cells at 30 mg/kg dose compared to FFD-fed vehicle controls.
Significantly reduced body weight, liver weight, liver-to-body weight ratio, serum ALT levels, serum cholesterol levels, NAFLD Activity Score, hepatic collagen deposition (Sirius Red-positive area), mRNA expression of pro-inflammatory genes (Ccl2, Ccl3, Cxcl2), mRNA expression of profibrogenic genes (Col1a1, Col1a4, Lox, Timp1), hepatic levels of phosphorylated AKT, JNK, and P65, and the percentage of CLEC4F-positive Kupffer cells at 60 mg/kg dose compared to FFD-fed vehicle controls.
Chemical Information
-
CAS No. 945457-84-1
-
분자량 412.29
-
화학식 C16H15Cl2N5O2S
-
SMILES
N(CC1=CC(Cl)=CC=C1)C2=C3C(N(C=N3)[C@H]4[C@H](O)[C@H](O)CS4)=NC(Cl)=N2
-
Synonyms
FM101
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Nephrotoxicity Study
This protocol assesses nephrotoxicity by combining functional kidney injury readouts, urinary/tissue injury biomarkers, and renal histopathology. Serum creatinine and BUN reflect impaired kidney function, while KIM-1, NGAL, clusterin, osteopontin, IL-18, cystatin C, nephrin, Oat5, urinary protein, glucose, and alkaline phosphatase have been used to detect tubular injury in cisplatin-, gentamicin-, and acetaminophen-induced nephrotoxicity models.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
순도&문서
References
[1]. Boo HJ, et al. LJ-2698, an Adenosine A3 Receptor Antagonist, Alleviates Elastase-Induced Pulmonary Emphysema in Mice. Biomol Ther (Seoul). 2020;28(3):250-258. [Content Brief]
[2]. Dorotea D, et al. Orally active, species-independent novel A3 adenosine receptor antagonist protects against kidney injury in db/db mice. Exp Mol Med. 2018 Apr 20;50(4):1-14. [Content Brief]
[3]. Park JS, et al.. A3AR antagonism mitigates metabolic dysfunction-associated steatotic liver disease by exploiting monocyte-derived Kupffer cell necroptosis and inflammation resolution. Metabolism: clinical and experimental. 2025 Mar;164:156114. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)